High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial. [electronic resource]
Producer: 20141216Description: 1206-8 p. digitalISSN:- 1029-2403
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.